Literature DB >> 21303016

Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease.

J Rusz1, R Cmejla, H Ruzickova, E Ruzicka.   

Abstract

An assessment of vocal impairment is presented for separating healthy people from persons with early untreated Parkinson's disease (PD). This study's main purpose was to (a) determine whether voice and speech disorder are present from early stages of PD before starting dopaminergic pharmacotherapy, (b) ascertain the specific characteristics of the PD-related vocal impairment, (c) identify PD-related acoustic signatures for the major part of traditional clinically used measurement methods with respect to their automatic assessment, and (d) design new automatic measurement methods of articulation. The varied speech data were collected from 46 Czech native speakers, 23 with PD. Subsequently, 19 representative measurements were pre-selected, and Wald sequential analysis was then applied to assess the efficiency of each measure and the extent of vocal impairment of each subject. It was found that measurement of the fundamental frequency variations applied to two selected tasks was the best method for separating healthy from PD subjects. On the basis of objective acoustic measures, statistical decision-making theory, and validation from practicing speech therapists, it has been demonstrated that 78% of early untreated PD subjects indicate some form of vocal impairment. The speech defects thus uncovered differ individually in various characteristics including phonation, articulation, and prosody.

Entities:  

Mesh:

Year:  2011        PMID: 21303016     DOI: 10.1121/1.3514381

Source DB:  PubMed          Journal:  J Acoust Soc Am        ISSN: 0001-4966            Impact factor:   1.840


  55 in total

1.  Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.

Authors:  Jan Rusz; Roman Cmejla; Hana Růžičková; Jiří Klempíř; Veronika Majerová; Jana Picmausová; Jan Roth; Evžen Růžička
Journal:  J Neural Transm (Vienna)       Date:  2012-07-08       Impact factor: 3.575

Review 2.  Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation.

Authors:  L Brabenec; J Mekyska; Z Galaz; Irena Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2017-01-18       Impact factor: 3.575

3.  Understanding diseases as increased heterogeneity: a complex network computational framework.

Authors:  Massimiliano Zanin; Juan Manuel Tuñas; Ernestina Menasalvas
Journal:  J R Soc Interface       Date:  2018-08       Impact factor: 4.118

4.  Effect of dopaminergic medication on speech dysfluency in Parkinson's disease: a longitudinal study.

Authors:  Tereza Tykalová; Jan Rusz; Roman Čmejla; Jiří Klempíř; Hana Růžičková; Jan Roth; Evžen Růžička
Journal:  J Neural Transm (Vienna)       Date:  2015-01-13       Impact factor: 3.575

5.  Identification of swallowing disorders in early and mid-stage Parkinson's disease using pattern recognition of pharyngeal high-resolution manometry data.

Authors:  C A Jones; M R Hoffman; L Lin; S Abdelhalim; J J Jiang; T M McCulloch
Journal:  Neurogastroenterol Motil       Date:  2017-11-16       Impact factor: 3.598

6.  A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse.

Authors:  Jan Rusz; Marika Megrelishvili; Cecilia Bonnet; Michael Okujava; Hana Brožová; Irine Khatiashvili; Madona Sekhniashvili; Marina Janelidze; Eduardo Tolosa; Evžen Růžička
Journal:  J Neural Transm (Vienna)       Date:  2014-01-21       Impact factor: 3.575

7.  Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.

Authors:  Jan Rusz; Cecilia Bonnet; Jiří Klempíř; Tereza Tykalová; Eva Baborová; Michal Novotný; Aaron Rulseh; Evžen Růžička
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

8.  Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease.

Authors:  Laura M Grant; Franziska Richter; Julie E Miller; Stephanie A White; Cynthia M Fox; Chunni Zhu; Marie-Francoise Chesselet; Michelle R Ciucci
Journal:  Behav Neurosci       Date:  2014-04       Impact factor: 1.912

9.  Characteristics and occurrence of speech impairment in Huntington's disease: possible influence of antipsychotic medication.

Authors:  Jan Rusz; Jiří Klempíř; Tereza Tykalová; Eva Baborová; Roman Čmejla; Evžen Růžička; Jan Roth
Journal:  J Neural Transm (Vienna)       Date:  2014-05-09       Impact factor: 3.575

10.  Assessment of voice and speech symptoms in early Parkinson's disease by the Robertson dysarthria profile.

Authors:  Giovanni Defazio; Marta Guerrieri; Daniele Liuzzi; Angelo Fabio Gigante; Vincenzo di Nicola
Journal:  Neurol Sci       Date:  2015-11-28       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.